Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics
Authors: Joshua A. Barocas
Journal: Annals of Internal Medicine (2019)

Letters2 April 2019Actions to Integrate Treatment of Opioid and Infectious Disease EpidemicsJoshua A. Barocas, MDJoshua A. Barocas, MDBoston University School of Medicine and Boston Medical Center, Boston, Massachusetts (J.A.B.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L19-0041 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:I read Springer and colleagues' commentary (1) with interest. The U.S. Department of Health and Human Services and all of the participants in the 2018 workshop “Integrating Infectious Disease Considerations with Response to the Opioid Epidemic” showed exceptional leadership by providing the 5 action steps as a framework from which we can continue to fight this epidemic.Hospitals and clinics should ensure that protocols are implemented for screening, immediate treatment, and linkage to care for persons with OUD. However, professional societies can also play a substantial role. Competing demands for time—including that spent on clinical care, administrative ...References1. Springer SA, Korthuis PT, Del Rio C. Integrating treatment at the intersection of opioid use disorder and infectious disease epidemics in medical settings: a call for action after a National Academies of Sciences, Engineering, and Medicine workshop. Ann Intern Med. 2018;169:335-6. [PMID: 30007032]. doi:10.7326/M18-1203 LinkGoogle Scholar2. Andrilla CHA, Coulthard C, Larson EH. Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med. 2017;15:359-62. [PMID: 28694273] doi:10.1370/afm.2099 CrossrefMedlineGoogle Scholar3. Andraka-Christou B, Capone MJ. A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices. Int J Drug Policy. 2018;54:9-17. [PMID: 29324253] doi:10.1016/j.drugpo.2017.11.021 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts (J.A.B.)Disclaimer: Dr. Barocas is an instructor for the Providers Clinical Support System course discussed here.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L19-0041. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoIntegrating Treatment at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics in Medical Settings: A Call for Action After a National Academies of Sciences, Engineering, and Medicine Workshop Sandra A. Springer , P. Todd Korthuis , and Carlos del Rio Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics Sandra A. Springer , P. Todd Korthuis , and Carlos del Rio Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics Simeon D. Kimmel , Raagini Jawa , Alexander Y. Walley , and Tamar F. Barlam Metrics 2 April 2019Volume 170, Issue 7Page: 509KeywordsDisclosureHospitalsInfectious diseasesOpioid use disorderOpioids ePublished: 2 April 2019 Issue Published: 2 April 2019 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...